Dose-Response Relationship between Post-Progression Bevacizumab Exposure and Survival among Metastatic Colorectal Cancer Patients

被引：0
|
作者：
Flick, E. Dawn [1 ]
Barr, Charles E. [1 ]
Fish, Susan M. [1 ]
Leon, Larry F. [1 ]
Mun, Yong [1 ]
Dalal, Darshan [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2012年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
520
引用
收藏
页码：244 / 245
页数：2
相关论文
共 50 条
  • [1] Correlation Between Bevacizumab Exposure and Survival in Patients with Metastatic Colorectal Cancer
    Papachristos, Apostolos
    Kemos, Polychronis
    Kalofonos, Haralabos
    Sivolapenko, Gregory
    ONCOLOGIST, 2020, 25 (10): : 853 - 858
  • [2] The relationship between progression-free and post-progression survival in treating four types of metastatic cancer
    Bowater, Russell J.
    Bridge, Luke J.
    Lilford, Richard J.
    CANCER LETTERS, 2008, 262 (01) : 48 - 53
  • [3] Assessment of exposure-response relationship for bevacizumab in patients with metastatic colorectal cancer
    Pena-Cabia, Silvia
    Royuela Vicente, Ana
    Ramos Diaz, Ruth
    Gutierrez Nicolas, Fernando
    Penalver Vera, Angela
    Siso Garcia, Isabel
    Hitt Sabag, Ricardo
    Garcia Lacalle, Concepcion
    Pena-Cabia, Ana
    Iglesias-Peinado, Irene
    Garcia Diaz, Benito
    Lopez-Martin, Ana
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 141
  • [4] Role of bevacizumab as post-progression maintenance therapy in metastatic colon cancer
    Galal, K. M.
    Abdel-Salam, M.
    Esmat, E. F.
    Mansour, S.
    Zaghlol, K. D.
    Mostafa, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Correlation of progression-free and post-progression survival with overall survival in advanced colorectal cancer
    Petrelli, F.
    Barni, S.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 186 - 192
  • [6] Modeling post-progression survival in patients with HER2-positive metastatic gastric cancer
    Chae, Dong Woo
    Kim, Joo Hoon
    Kim, Chan
    Chon, Hong Jae
    Lee, Choong-kun
    Kim, Hyo Song
    Jung, Minkyu
    Chung, Hyun Cheol
    Rha, Sun Young
    Park, Kyung Soo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] The use of bevacizumab is correlated with improved post-progression survival in advanced recurrent ovarian cancer
    Yanazume, Shintaro
    Ushiwaka, Takashi
    Fukuda, Mika
    Togami, Shinichi
    Kamio, Masaki
    Kobayashi, Hiroaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (09) : 1407 - 1415
  • [8] Clinical Impact of the Relationship between Post-Progression Survival and Overall Survival in Extensive Disease Small Cell Lung Cancer Patients
    Imai, Hisao
    Mori, Keita
    Watase, Nodoka
    Fujimoto, Sakae
    Kaira, Kyoichi
    Yamada, Masanobu
    Minato, Koichi
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S726 - S727
  • [9] Dose-Response Relationship between Serum Retinol Levels and Survival in Patients with Colorectal Cancer: Results from the DACHS Study
    Maalmi, Haifa
    Walter, Viola
    Jansen, Lina
    Owen, Robert W.
    Ulrich, Alexis
    Schoettker, Ben
    Chang-Claude, Jenny
    Hoffmeister, Michael
    Brenner, Hermann
    NUTRIENTS, 2018, 10 (04):
  • [10] Effect of continuation of bevacizumab following disease progression in patients with metastatic colorectal cancer on survival
    Samelis, G. F.
    Tsiakou, A.
    Karamanidi, M.
    Pelechrini, M.
    Zaganides, A.
    Ekmektzoglou, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345